Literature DB >> 21365363

Reactive lymphoid hyperplasia of liver mimicking late ovarian cancer recurrence: case report and literature review.

Claudia Marchetti1, Natalina Manci, Marco Di Maurizio, Chiara Di Tucci, Moira Burratti, Marialetizia Iuliano, Margherita Giorgini, Laura Salerno, Pierluigi Benedetti Panici.   

Abstract

Reactive lymphoid hyperplasia (RLH) is a rare, benign, lymphocytic tumour-like lesion reported in various organs. It has been previously identified in 18 cases in the English-language literature, but only 5 of them were related to oncological disease. No previous cases have been described of RLH occurring in ovarian cancer patients. We describe a case of hepatic RLH which developed in a patient treated for ovarian cancer 11 years previously. Radiological features on computed tomography (CT) scan and PET-CT (positron emission tomography-computed tomography) were strongly suggestive of oncological disease, in contrast to magnetic resonance imaging (MRI); the volume increment of the nodular lesion and the rise in carbohydrate antigen 125 corroborated the hypothesis of malignancy. The patient was subjected to resection of the 7th segment of the liver and the final histological report showed RLH. RLH should be considered in the presence of hepatic lesions in suspected ovarian cancer recurrence. Imaging techniques should be thoroughly investigated to exclude tumor recurrence promptly, in order to avoid unnecessary surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21365363     DOI: 10.1007/s10147-011-0191-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  10 in total

1.  Pathologic quiz case: Hepatic mass in a patient with renal cell carcinoma.

Authors:  L Pantanowitz; P F Saldinger; M E Kadin
Journal:  Arch Pathol Lab Med       Date:  2001-04       Impact factor: 5.534

Review 2.  Reactive lymphoid hyperplasia of the liver in a patient with multiple carcinomas: a case report and brief review.

Authors:  K Sato; Y Ueda; M Yokoi; K Hayashi; T Kosaka; S Katsuda
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

3.  Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer.

Authors:  Pierluigi Benedetti Panici; Antonio De Vivo; Filippo Bellati; Natalina Manci; Giorgia Perniola; Stefano Basile; Ludovico Muzii; Roberto Angioli
Journal:  Ann Surg Oncol       Date:  2006-12-31       Impact factor: 5.344

Review 4.  A case of pseudolymphoma of the liver with chronic hepatitis C.

Authors:  S R Kim; Y Hayashi; K B Kang; C G Soe; J H Kim; M K Yang; H Itoh
Journal:  J Hepatol       Date:  1997-01       Impact factor: 25.083

5.  Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.

Authors:  Dennis S Chi; Kristina McCaughty; John P Diaz; Jae Huh; Sarah Schwabenbauer; Amanda J Hummer; Ennapadam S Venkatraman; Carol Aghajanian; Yukio Sonoda; Nadeem R Abu-Rustum; Richard R Barakat
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

Review 6.  Recurrent ovarian malignancy: patterns and spectrum of imaging findings.

Authors:  C M Park; S H Kim; S H Kim; M H Moon; K W Kim; H J Choi
Journal:  Abdom Imaging       Date:  2003 May-Jun

Review 7.  Reactive lymphoid hyperplasia of the liver: a case report and review of literature.

Authors:  Takuro Machida; Toshiyuki Takahashi; Tomoo Itoh; Michiaki Hirayama; Takayuki Morita; Shoichi Horita
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

Review 8.  Serum tumor markers in the management of ovarian, endometrial and cervical cancer.

Authors:  Angiolo Gadducci; Stefania Cosio; Angelo Carpi; Andrea Nicolini; Andrea Riccardo Genazzani
Journal:  Biomed Pharmacother       Date:  2004-01       Impact factor: 6.529

9.  Metastatic patterns at autopsy in patients with ovarian carcinoma.

Authors:  Uwe Güth; Dorothy Jane Huang; Gregor Bauer; Marco Stieger; Edward Wight; Gad Singer
Journal:  Cancer       Date:  2007-09-15       Impact factor: 6.860

10.  Reactive lymphoid hyperplasia of the liver in a patient with colon cancer: report of two cases.

Authors:  Hiroki Takahashi; Hirozumi Sawai; Yoichi Matsuo; Hitoshi Funahashi; Mikinori Satoh; Yuji Okada; Hiroshi Inagaki; Hiromitsu Takeyama; Tadao Manabe
Journal:  BMC Gastroenterol       Date:  2006-09-12       Impact factor: 3.067

  10 in total
  6 in total

1.  Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography.

Authors:  Kazuhiro Suzumura; Etsuro Hatano; Toshihiro Okada; Yasukane Asano; Naoki Uyama; Seikan Hai; Ami Kurimoto; Kentaro Nonaka; Tohru Tsujimura; Jiro Fujimoto
Journal:  Case Rep Gastroenterol       Date:  2017-12-21

2.  A case of reactive lymphoid hyperplasia of the liver in a patient with autoimmune hepatitis.

Authors:  Hiroki Kanno; Hisamune Sakai; Toru Hisaka; Satoki Kojima; Ryuta Midorikawa; Shogo Fukutomi; Yoriko Nomura; Yuichi Goto; Toshihiro Sato; Munehiro Yoshitomi; Ryuichi Kawahara; Koji Okuda
Journal:  Surg Case Rep       Date:  2020-05-04

3.  Diffusion-weighted imaging might be useful for reactive lymphoid hyperplasia diagnosis of the liver: A case report.

Authors:  Taro Tanaka; Kazuhiro Saito; Daisuke Yunaiyama; Jun Matsubayashi; Yuichi Nagakawa; Maki Tanigawa; Toshitaka Nagao
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

4.  Reactive lymphoid hyperplasia of the liver.

Authors:  Woo Sung Moon; Keum Ha Choi
Journal:  Clin Mol Hepatol       Date:  2013-03

5.  Pseudolymphoma of the liver: a case report and literature review.

Authors:  Kazuhiro Taguchi; Shintaro Kuroda; Tsuyoshi Kobayashi; Hirotaka Tashiro; Kohei Ishiyama; Kentaro Ide; Masahiro Ohira; Hiroyuki Tahara; Koji Arihiro; Hideki Ohdan
Journal:  Surg Case Rep       Date:  2015-10-17

6.  Intrahepatic Reactive Lymphoid Hyperplasia: A Case Report and Review of the Literature.

Authors:  Samantha Seitter; Zachary D Goodman; Theodore M Friedman; Timothy R Shaver; George Younan
Journal:  Case Rep Surg       Date:  2018-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.